Dianthus Therapeutics Inc
F:87E
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dianthus Therapeutics Inc
F:87E
|
US |
|
A
|
Amex Exploration Inc
F:MX0
|
CA |
|
Bhakti Agung Propertindo Tbk PT
IDX:BAPI
|
ID |
|
A
|
Altri SGPS SA
XMUN:ACJ
|
PT |
|
C
|
Captivision Inc
NASDAQ:CAPT
|
UK |
|
Ala SpA
F:8WD
|
IT |
|
B
|
Bitros Holding SA
ATHEX:MPITR
|
GR |
|
A
|
Ahlers AG
DUS:AAH
|
DE |
|
Everock Inc
OTC:EVRN
|
US |
|
C
|
Crown Resorts Ltd
F:5CW
|
AU |
|
T
|
Tera Data Indonusa Tbk PT
IDX:AXIO
|
ID |
|
C
|
Codelab Capital AS
OSE:CODE
|
NO |
|
Westkam Gold Corp
XTSX:BEAR
|
CA |
|
O
|
Orogen Royalties Inc
F:5EV
|
CA |
|
M
|
Mundoro Capital Inc
F:NGU
|
CA |
Shareholder Yield
Current shareholder yield for 
87E is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
87E Price
Dianthus Therapeutics Inc
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -20% |
| Market Capitalization | 6B EUR |
| Shares Outstanding | 42 880 000 |
| Percentage of Shares Shorted |
N/A
|
